ANDROPHARMA CURVATURE TRATAMIENTO PEYRONIE

ANDROPHARMA - CURVATURE PEYRONIE TREATMENT

PACKAGING AVAILABLE IN: /es/en/fr/de/nl/dk/it/se/ru/jp/ar/

ANDROPHARMA CURVATURE TRATAMIENTO PEYRONIE
ANDROPHARMA CURVATURE TRATAMIENTO PEYRONIE
ANDROPHARMA CURVATURE TRATAMIENTO PEYRONIE
Status: NEWIN STOCK FREE Shipping Cost order more of 500€* ( United Kingdom, Italy, Germany, France)
29,95
10.00% VAT included
Dimensions: 116 x 30 x 165 millimeters
Weight: 50 grams

Andropharma Curvature supplements help fight Peyronie's disease

Current studies show that Peyronie's disease (plastic induration of the penis) is an inflammatory disease of the penis where the elastic layer (tunica albuginea) of the penis in the central tissue (corpora cavernosa) is injured. Consequently, the affected area loses elasticity and when filled with blood it does not stretch, but rather causes the penis to curve in the direction of the scar. Peyronie's disease is the most common cause of excessive penile curvature.

The process begins with the oxidation of various fats and protein molecules that lead to inflammation of the elastic layer (tunica albuginea) and the corpus cavernosum. This continues until finally the collagen fibers are replaced by non-elastic fibers that form the fibrous plaque (hardened nodules) very characteristic of this disease.

These plaques can be felt under the skin, usually on the top or sometimes on the sides of the penis. Most of them dissolve on their own naturally, but sometimes they persist and over time cause:

Abnormal curvature of the penis (often upwards));

  • Erectile dysfunction and/or pain during erection;
  • Shortening, loss of thickness and/or malformation of the penis (indentations, bottlenecks, hourglass shape);
  • Sexual problems caused by anxiety and psychological problems.

Currently available treatments are not yet completely satisfactory and mostly only help to relieve the symptoms of Peyronie's disease. For less complicated cases and the initial stages there are numerous medications and compounds (most are anti-inflammatory and anti-sclerosing) that are used and tested.

If the curvature of the penis persists in the later phases of the disease, when the pain has already decreased, it is necessary to resort to surgery to correct it.

However, this treatment is very invasive and can sometimes result in penile shortening that can be up to 4 cm (1.6 inches).

 

Urology and Andrology are the specialists who are investigating other non-invasive options. Recently there have been several studies on the effect of penis extenders such as Andropeyronie which uses traction force to help correct penile curvature and reduce fibrotic plaques. The results have shown that it is effective and totally safe to correct the curvature of the penis.

  • Promote blood circulation and metabolism;
  • help relieve pain;
  • reduce the process associated with fibrous plaques and penile curvature

It contains 30 capsules, equivalent to one month's consumption.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Launch date

Friday, 15 December 2023